PAVmed Inc.

PAVM Nasdaq CIK: 0001624326

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 360 MADISON AVENUE, NEW YORK, NY, 10017
Mailing Address 360 MADISON AVENUE, NEW YORK, NY, 10017
Phone (212) 949-4319
Fiscal Year End 1231
EIN 471214177

Financial Overview

FY2024 FY

$3.00M
Revenue
$33.12M
Total Assets
$57.14M
Total Liabilities
$19.64M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13D/A Beneficial ownership amendment February 9, 2026 View on SEC
8-K Current report of material events February 4, 2026 View on SEC
8-K Current report of material events January 23, 2026 View on SEC
8-K Current report of material events December 30, 2025 View on SEC
8-K Current report of material events December 5, 2025 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
10-Q Quarterly financial report November 12, 2025 View on SEC
DEF 14A Definitive proxy statement October 31, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment October 10, 2025 View on SEC
4 Insider stock transaction report October 2, 2025 View on SEC

Material Events

8-K Other January 23, 2026
High Impact
  • PAVmed Inc. has successfully regained full compliance with Nasdaq's listing requirements.
  • This resolution removes the risk of delisting, protecting shareholder value and maintaining stock accessibility.
View Analysis
8-K Financial Distress December 30, 2025
High Impact
  • PAVmed Inc. announced a 1-for-30 reverse stock split.
  • The company is also significantly reducing its total authorized shares from 250 million to 25 million.
View Analysis
8-K Strategy Change December 5, 2025
High Impact
  • PAVmed stockholders approved a reverse stock split and a significant reduction in the total number of authorized shares.
  • The board of directors now has the power to implement a reverse stock split with a ratio between 1-for-10 and 1-for-30.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.